ArticleScientific reports2026
Confidence: a web app for cross-platform differential gene expression analysis, gene scoring, and enrichment analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA-seq quantifies the abundance of transcripts within a biological sample and performs differential analysis between different conditions to reveal regulated gene signatures. Three challenges exist: (1) different analytical packages can often report different expression patterns and false-discovery-rates and P-values; (2) the effective use of these analytical packages requires substantial knowledge of programming and bioinformatics; and (3) there are a lack of intuitive methods to prioritize target genes for further investigation. To address these challenges, we developed Confidence, a web-based application to perform simultaneous statistical analysis of RNA-seq count data. Confidence incorporates the Confidence Score (CS), ranging from 1 to 4 to aid in gene prioritization, where 1 represents low confidence and 4 represents high confidence. The Confidence web-based application was designed for rapid and intuitive analysis of standard experimental metadata and gene count inputs providing a web-based, 'wide-net' approach to RNA-seq analysis. Gene scoring allows for unbiased gene selection and identification of novel genes strongly associated with disease/treatment models across multiple species. Pathway analysis has been integrated so that highly confident genes can be placed into biological context. Confidence provides a new strategy for target prioritization in RNA-seq analysis and the generation of publication-quality figures, which we demonstrate here using a published database.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.